 OSAKA, Japan--BUSINESS WIRE--Takeda Pharmaceutical Company Limited TSE:4502NYSE:TAK Takeda today announced the receipt of a decision by the Irish Tax Appeals Commission on July 30, 2021 IST to uphold the Irish Revenue Commissioners position related to the treatment of a break fee received by Shire plc Shire in October 2014 from AbbVie Inc. AbbVie. Shire was acquired by Takeda in January 2019. Takeda intends to challenge this outcome through all available legal means includin 